Vibhu Jha

Has grant

Assistant Professor in Computational Drug Design

University of Bradford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vibhu Jha is an Assistant Professor in Computational Drug Design at the University of Bradford, UK. His research focuses on network pharmacology, molecular docking, and dynamics, particularly in the context of developing novel therapeutic agents for cancer and Alzheimer's disease. Recent publications include explorations of natural compounds for liver cancer chemotherapy and the design of dual-targeted anticancer agents. He is also engaged in advancing the application of artificial intelligence within pharmaceutical sciences.

Recent Grants

Grant: Close

Machine learning and structure-based development of MTHFD2 inhibitors for cancer therapy

Open Date: 2022-04-01

Close Date: 2024-03-01

Grant: Close

Fragment-based discovery of new antitubercular and antimalarial agents by structure-based, ligand-based and machine learning approaches targeting aminoacyl tRNA synthetases

Open Date: 2021-03-01

Close Date: 2023-02-01

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (1)

Leif A. Eriksson

Professor of Physical Chemistry

University of Gothenburg

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vibhu Jha

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Unraveling the Binding Mode of TSC2–Rheb through Protein Docking and Simulations

Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents

Computational Network Pharmacology, Molecular Docking, and Molecular Dynamics to Decipher Natural Compounds of Alchornea laxiflora for Liver Cancer Chemotherapy

Design and development of sulfenylated 5-aminopyrazoles as inhibitors of acetylcholinesterase and butyrylcholinesterase: exploring the implication for Aβ<sub>1-42</sub> aggregation inhibition in Alzheimer's disease

Dess-Martin periodinane-mediated oxidation of the primary alcohol of cytidine into a carboxylic acid

Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition

Repurposing of USFDA-approved drugs to identify leads for inhibition of acetylcholinesterase enzyme: a plausible utility as an anti-Alzheimer agent

Selectivity analysis of diaminopyrimidine-based inhibitors of MTHFD1, MTHFD2 and MTHFD2L

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2

Binding Analysis and Structure-Based Design of Tricyclic Coumarin-Derived MTHFD2 Inhibitors as Anticancer Agents: Insights from Computational Modeling

Collaborators (1)

Leif A. Eriksson

Make your next move.